| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
|
Joharatnam-Hogan, Nalinie
|
|
2019
|
4 |
11 |
p. 854-862
|
artikel
|
| 2 |
Aspirin, cancer, and bleeding: an equation to solve
|
Lanas, Angel
|
|
2019
|
4 |
11 |
p. 815-816
|
artikel
|
| 3 |
Australians wait longer for colonoscopies
|
Burki, Talha K
|
|
2019
|
4 |
11 |
p. 827-828
|
artikel
|
| 4 |
Budd-Chiari syndrome with short-length stenosis: still room for the angioplasty and wait-and-see strategy
|
Ferrusquía-Acosta, José
|
|
2019
|
4 |
11 |
p. 823
|
artikel
|
| 5 |
Budd-Chiari syndrome with short-length stenosis: still room for the angioplasty and wait-and-see strategy – Authors' reply
|
Wang, Qiuhe
|
|
2019
|
4 |
11 |
p. 823-824
|
artikel
|
| 6 |
Chronic constipation: new insights, better outcomes?
|
Schiller, Lawrence R
|
|
2019
|
4 |
11 |
p. 873-882
|
artikel
|
| 7 |
Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial
|
Everitt, Hazel A
|
|
2019
|
4 |
11 |
p. 863-872
|
artikel
|
| 8 |
Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis
|
Luthra, Pavit
|
|
2019
|
4 |
11 |
p. 831-844
|
artikel
|
| 9 |
Improving access to gut–brain therapies for IBS
|
Taft, Tiffany H
|
|
2019
|
4 |
11 |
p. 816-818
|
artikel
|
| 10 |
Intestinal and hepatic fibrosis: how are they similar?
|
D'Haens, Geert
|
|
2019
|
4 |
11 |
p. 820-822
|
artikel
|
| 11 |
Network meta-analysis in chronic constipation: what have we learned?
|
Schiller, Lawrence R
|
|
2019
|
4 |
11 |
p. 812-813
|
artikel
|
| 12 |
NeuroGASTRO 2019
|
Pinion, Sheila
|
|
2019
|
4 |
11 |
p. 825
|
artikel
|
| 13 |
Oesophageal cancer hotspots in Africa
|
Kayamba, Violet
|
|
2019
|
4 |
11 |
p. 818-820
|
artikel
|
| 14 |
Poopology: a serious game for a serious illness
|
Cleghorn, Sean
|
|
2019
|
4 |
11 |
p. 828-829
|
artikel
|
| 15 |
Research in brief
|
Baker, Holly
|
|
2019
|
4 |
11 |
p. 826
|
artikel
|
| 16 |
Safety of anti-TNF biologics in paediatric inflammatory bowel disease
|
Ruemmele, Frank M
|
|
2019
|
4 |
11 |
p. 813-815
|
artikel
|
| 17 |
Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure
|
Asselah, Tarik
|
|
2019
|
4 |
11 |
p. 883-892
|
artikel
|
| 18 |
The cost of constipation
|
The Lancet Gastroenterology & Hepatology,
|
|
2019
|
4 |
11 |
p. 811
|
artikel
|
| 19 |
The rise of irritable bowel syndrome apps
|
Burki, Talha K
|
|
2019
|
4 |
11 |
p. 829-830
|
artikel
|
| 20 |
Use of tumour necrosis factor-α inhibitors and the risk of serious infection in paediatric inflammatory bowel disease in Denmark: a nationwide cohort study
|
Wintzell, Viktor
|
|
2019
|
4 |
11 |
p. 845-853
|
artikel
|
Tijdschrift beschrijving